Buy One Get One free -Llimited Time Offer X
Denrit is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Non-Small Cell Lung Cancer. Secondary and off-label uses of Denrit have also been mentioned below.
The correct dosage of Denrit depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Denrit are Weakness, Dry Skin, Dark colored (brown) urine. Apart from the aforementioned side effects, Denrit can also lead to other problems, which have been listed below. Usually, these side effects of Denrit go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Denrit has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Denrit related warnings talks about Denrit's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Disease, Gastritis must refrain from the use of Denrit since this can cause severe adverse effects. Other conditions have been mentioned below in the Denrit contraindications section.
Drug interactions for Denrit have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Denrit is considered not safe while driving, and is not addictive.
Denrit is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Denrit is used -
Severe
Moderate
Mild
Common
Is the use of Denrit safe for pregnant women?
Denrit should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Denrit safe during breastfeeding?
Denrit should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Denrit on the Kidneys?
Denrit rarely harms the kidneys.
What is the effect of Denrit on the Liver?
Denrit has very mild side effects on the liver.
What is the effect of Denrit on the Heart?
You can take Denrit without any fear of damage to the heart.
Denrit should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Denrit unless your doctor advises you to do so -
Is this Denrit habit forming or addictive?
Forming a habit of Denrit has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Denrit. So it is best to avoid driving.
Is it safe?
Denrit is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Denrit for mental disorders.
Interaction between Food and Denrit
Taking Denrit with food does not cause any problems.
Interaction between Alcohol and Denrit
Information about the interaction of Denrit and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Iressa (gefitinib tablets)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 610-612